RxDoctor Payments Data

Justin Smith, PA

Medical · Gainesville, GANPI 1376879825

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 487 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 25.2% of the total. Reporting peaked in 2024 at $2,617 and has fallen 63.7% since, to $949 in 2025. Among medical clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,127in general payments, 2019–2025

Across 487 payments — averaging $20.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Sanofi$1K
  • LEO Pharma Inc.$929
  • Johnson & Johnson$829
  • Novartis$624
  • Pfizer$487
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$9,62495%
  • Education$5035%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,127 in reported general payments places this provider in the 90th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia

Medicare billing

Part B allowed, 2024
$178,547
Medicare patients
768
Services billed
4,363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab53$209,595
Cosentyx Sensoready (2 Pens)Secukinumab17$118,297
Clobetasol Propionate61$2,639
Fluorouracil16$1,131
Fluocinonide33$1,061
Doxycycline Hyclate59$1,026
Metronidazole20$936
Triamcinolone Acetonide69$874
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc65$823
Ketoconazole61$754
CiclopiroxCiclopirox Olamine33$568
Clindamycin Phosphate22$548
Hydrocortisone65$471
ValacyclovirValacyclovir Hcl15$261
Mupirocin26$174

Paid to pharmacies, not to this prescriber.

Other medical in Gainesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →